Cargando…

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"

There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Schlander, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947902/
https://www.ncbi.nlm.nih.gov/pubmed/32610783
http://dx.doi.org/10.34172/ijhpm.2020.22
_version_ 1783663324346449920
author Schlander, Michael
author_facet Schlander, Michael
author_sort Schlander, Michael
collection PubMed
description There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentation of value") and the lack of a broadly accepted, ethically defensible analytical framework, and (ii) the well-documented loopholes of the conventional logic of cost-effectiveness (CE) with its reductionist concept of allocative efficiency, which fails to reflect the distributive dimension of resource allocation decisions in collectively financed health schemes.
format Online
Article
Text
id pubmed-7947902
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-79479022021-03-16 HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" Schlander, Michael Int J Health Policy Manag Commentary There are at least two reasons why health technology assessment (HTA) agencies need to seek process-based solutions to support the legitimacy of healthcare resource allocation, ie, (i) in pluralistic societies, the existence of often conflicting and incommensurable claims (ie, the "fragmentation of value") and the lack of a broadly accepted, ethically defensible analytical framework, and (ii) the well-documented loopholes of the conventional logic of cost-effectiveness (CE) with its reductionist concept of allocative efficiency, which fails to reflect the distributive dimension of resource allocation decisions in collectively financed health schemes. Kerman University of Medical Sciences 2020-02-19 /pmc/articles/PMC7947902/ /pubmed/32610783 http://dx.doi.org/10.34172/ijhpm.2020.22 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Schlander, Michael
HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title_full HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title_fullStr HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title_full_unstemmed HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title_short HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
title_sort hta agencies need evidence-informed deliberative processes comment on "use of evidence-informed deliberative processes by health technology assessment agencies around the globe"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947902/
https://www.ncbi.nlm.nih.gov/pubmed/32610783
http://dx.doi.org/10.34172/ijhpm.2020.22
work_keys_str_mv AT schlandermichael htaagenciesneedevidenceinformeddeliberativeprocessescommentonuseofevidenceinformeddeliberativeprocessesbyhealthtechnologyassessmentagenciesaroundtheglobe